Evaluation of Neuropathy, Glycemic Control, and Revascularization as Risk Factors for Future Lower Extremity Amputation among Diabetic Patients.

MLA

Goldman, Matthew P., et al. “Evaluation of Neuropathy, Glycemic Control, and Revascularization as Risk Factors for Future Lower Extremity Amputation among Diabetic Patients.” Annals of Vascular Surgery, vol. 73, May 2021, pp. 254–63. EBSCOhost, https://doi.org/10.1016/j.avsg.2020.10.022.

APA

Goldman, M. P., Corriere, M. A., Craven, T., Davis, R. P., Sheehan, M., Hurie, J. B., Velazquez, G., Williams, T. K., Chang, K., & Edwards, M. S. (2021). Evaluation of Neuropathy, Glycemic Control, and Revascularization as Risk Factors for Future Lower Extremity Amputation among Diabetic Patients. Annals of Vascular Surgery, 73, 254–263. https://doi.org/10.1016/j.avsg.2020.10.022

Chicago

Goldman, Matthew P, Matthew A Corriere, Timothy Craven, Ross P Davis, Maureen Sheehan, Justin B Hurie, Gabriella Velazquez, Timothy K Williams, Kevin Chang, and Matthew S Edwards. 2021. “Evaluation of Neuropathy, Glycemic Control, and Revascularization as Risk Factors for Future Lower Extremity Amputation among Diabetic Patients.” Annals of Vascular Surgery 73 (May): 254–63. doi:10.1016/j.avsg.2020.10.022.